Q3 2014 13F Holders as of 9/30/2014
-
Type / Class
-
Equity / Class A Stock
-
Shares outstanding
-
115M
-
Number of holders
-
161
-
Total 13F shares, excl. options
-
56.9M
-
Shares change
-
+3.17M
-
Total reported value, excl. options
-
$1.12B
-
Value change
-
+$39.7M
-
Number of buys
-
92
-
Number of sells
-
-86
-
Price
-
$19.67
Significant Holders of GLOBUS MEDICAL INC - Class A Stock (GMED) as of Q3 2014
197 filings reported holding GMED - GLOBUS MEDICAL INC - Class A Stock as of Q3 2014.
GLOBUS MEDICAL INC - Class A Stock (GMED) has 161 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 56.9M shares
of 115M outstanding shares and own 49.4% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT CO LLP (5.21M shares), VANGUARD GROUP INC (4.21M shares), OAK RIDGE INVESTMENTS LLC (2.65M shares), Champlain Investment Partners, LLC (2.37M shares), BlackRock Institutional Trust Company, N.A. (1.65M shares), Bank of New York Mellon Corp (1.62M shares), GANNETT WELSH & KOTLER (1.61M shares), BlackRock Fund Advisors (1.6M shares), CARDINAL CAPITAL MANAGEMENT LLC /CT (1.38M shares), and Cortina Asset Management, LLC (1.33M shares).
This table shows the top 161 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.